Patients and science are at the center of everything we do, defining and uniting our efforts across rare diseases, multiple sclerosis, oncology, and immunology MORE ABOUT US Areas of Focus RARE DISEASES 35+ years pioneering research for patients living with rare genetic conditions OUR WORK MULTIPLE SCLEROSIS 2.3 million people living with multiple sclerosis worldwide OUR WORK 2 therapies approved for immune-mediated diseases with several more in clinical trials OUR WORK IMMUNOLOGY 6 late-stage research programs focused on discovering new options for cancer patients OUR WORK ONCOLOGY News & Announcements OUR STORIES A Conversation with Multiple Sclerosis Researcher, Evis Havari May 30, 2018 MORE Quick Links Research Pipeline EXPLORE R&D HIGHLIGHTS Careers DISCOVER OPPORTUNITIES Patient Access to Treatment LEARN ABOUT OUR EFFORTS Get in Touch Send us a message via our online form CONTACT US SAUS.GZ.17.11.9171 Last update: 1/2018 Follow us Contact Us Terms of Use Privacy Policy This site is intended for United States residents only. ©2018 Genzyme Corporation. All rights reserved This website uses cookies to track its audience and improve its content. By continuing to browse this website, you agree to the use of such cookies. Click here for more information on cookies. OK